Podcasts about Myosin

For EP31 of Chain Reactions, we sat down with Bettina Sosa — one of the newest guild leads at Myosin and our DevRel whisperer — to unpack why every founder building in crypto needs to treat Developer Relations as a core part of their go-to-market motion.We trace Bettina's path from researching self-sovereign identity at Imperial College (shoutout to her Venezuelan roots and her early hopes to fix broken ID systems) to helping major DAOs like Aragon and Bankless with their onboarding UX. Along the way, she shares what it was like moving from research to shipping product, how she started writing dev-focused content to demystify EVM and MEV, and why so much DevRel in Web3 misses the mark.We go deep on what great DevRel actually looks like — beyond just hackathons and bounties — and explore everything from niche TG groups and cold outreach to AI learning tools, dev onboarding trends, and the regions everyone's sleeping on (spoiler: it's not just Asia anymore).If you're serious about growing your protocol, building developer ecosystems, or just want to understand why “just having docs” won't cut it — this one's for you.Please enjoy, and as always, don't forget to subscribe, give us a five-star review, and mint the episode at pods.media/myosinxyz!

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/QVF865. CME/MOC/AAPA credit will be available until April 28, 2026.Achieving Next-Level HCM Care and Outcomes With Cardiac Myosin Inhibition: From Long-Term Clinical Evidence to Real-World Data In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/QVF865. CME/MOC/AAPA credit will be available until April 28, 2026.Achieving Next-Level HCM Care and Outcomes With Cardiac Myosin Inhibition: From Long-Term Clinical Evidence to Real-World Data In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/QVF865. CME/MOC/AAPA credit will be available until April 28, 2026.Achieving Next-Level HCM Care and Outcomes With Cardiac Myosin Inhibition: From Long-Term Clinical Evidence to Real-World Data In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/QVF865. CME/MOC/AAPA credit will be available until April 28, 2026.Achieving Next-Level HCM Care and Outcomes With Cardiac Myosin Inhibition: From Long-Term Clinical Evidence to Real-World Data In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/QVF865. CME/MOC/AAPA credit will be available until April 28, 2026.Achieving Next-Level HCM Care and Outcomes With Cardiac Myosin Inhibition: From Long-Term Clinical Evidence to Real-World Data In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/QVF865. CME/MOC/AAPA credit will be available until April 28, 2026.Achieving Next-Level HCM Care and Outcomes With Cardiac Myosin Inhibition: From Long-Term Clinical Evidence to Real-World Data In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/QVF865. CME/MOC/AAPA credit will be available until April 28, 2026.Achieving Next-Level HCM Care and Outcomes With Cardiac Myosin Inhibition: From Long-Term Clinical Evidence to Real-World Data In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/QVF865. CME/MOC/AAPA credit will be available until April 28, 2026.Achieving Next-Level HCM Care and Outcomes With Cardiac Myosin Inhibition: From Long-Term Clinical Evidence to Real-World Data In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

For EP22 of Chain Reactions, we talked to Rom (@romully), Design Lead at Myosin.xyz, community building extraordinaire, and one of our top designers and brand builders within the network.Rom has an incredible background as a designer, and we had a really fun conversation all around the importance of brand building in the marketing stack in web3, how early stage founders can get started without big budgets, design trends we're seeing, and so much more.Please enjoy, and as always, be sure to subscribe, give us a five star review, and mint our episode at https://pods.media/myosinxyz!

Watch our panel of experts and get up to speed on hypertrophic cardiomyopathy (HCM) through a series of quickfire questions and teaching points. Credit available for this activity expires: 01/31/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/new-paradigms-hypertrophic-cardiomyopathy-care-gameshow-2025a10002f4?ecd=bdc_podcast_libsyn_mscpedu

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MEX865. CME/MOC/AAPA credit will be available until January 22, 2026.Remodeling Innovation: Applying Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM & Beyond In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

For EP18 of Chain Reactions, we talked to Alex Poon, Co-Founder of Scout Game and Charmverse, a friend of Myosin, and now repeat guest on the Myosin.xyz podcast.Scout Game is a fantasy sports game targeting developers, but open for anyone to play. With massive initial traction, we talked to Alex all about Scout Games' origins, how the game itself works, and Scout Games broader ambitions for expanding to more blockchains and ecosystems, and eventually the global open-source dev community at large. We're massively bullish on Scout Game, and think is an excellent listen for anyone who cares about developer marketing, gamification, and how to build products that are both fun and really solve a clear need. Please enjoy, and as always, be sure to subscribe, give us a five star review, and mint our episode at https://pods.media/myosinxyz!

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MEX865. CME/MOC/AAPA credit will be available until January 22, 2026.Remodeling Innovation: Applying Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM & Beyond In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MEX865. CME/MOC/AAPA credit will be available until January 22, 2026.Remodeling Innovation: Applying Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM & Beyond In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MEX865. CME/MOC/AAPA credit will be available until January 22, 2026.Remodeling Innovation: Applying Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM & Beyond In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MEX865. CME/MOC/AAPA credit will be available until January 22, 2026.Remodeling Innovation: Applying Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM & Beyond In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MEX865. CME/MOC/AAPA credit will be available until January 22, 2026.Remodeling Innovation: Applying Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM & Beyond In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

For EP16 of Chain Reactions, hot off the release of our Crypto in Argentina report, we talked to Mike Tango Bravo, Founder of Open Vino DAO and a Crecimiento community member, and Tay Todd, our Innovation Genius who helped write Myosin's Crypto in Argentina report. During our chat we talked all about the unique nature of Argentina's economic history and relationship with crypto, and just how and why it's so keen to adopt crypto with even government support and encouragement, as well as the unique and incredible nature of how Open Vino DAO is helping tokenize and democratize access to one of the oldest industries in the world: winemaking.This is a great listen for anyone trying to understand why crypto matters, and how it's fast gaining adoption in countries such as Argentina. Links below! https://bit.ly/myosin-argentina-rr https://x.com/crecimientoar https://openvino.org/

For EP14 of Chain Reactions, we chatted with James Fry, Head of Marketing for Risk Labs, the foundation and core team behind UMA & Across Protocols.We jammed out with James on why we need more protocols like UMA Protocol, which helps decentralized truth telling and powers popular prediction markets like Polymarket, and Across Protocol, which helps streamline and drastically improve cross-chain crypto transactions with what we call decentralized 'intents.' This was a big brain chat, and a great listen for anyone interested in the future of blockchain! Please enjoy, and tune in live on our Twitter at https://x.com/Myosin_xyz every Wed, at 11am EST.

For EP13 of Chain Reactions, we chatted with Kim Currier, Head of Partnership & Growth for Decentraland, one of the leading platforms for communities to gather and interact in virtual economies. We had a delightful time chatting with Kim about the latest updates to Decentraland and Decentraland 2.0, their gamification efforts, and waxing poetic about what the metaverse really is. Kim shared a lot of really interesting insights into the challenges and unique opportunities that marketing a world like Decentraland can bring for brands and companies of all kinds, and she also included some alpha that you definitely don't want to miss. Take a listen! Please enjoy, and tune in live on our Twitter at https://x.com/Myosin_xyz every Wed, at 11am EST.

For EP12 of Chain Reactions, we chatted with Nicole Rochette, Innovation Guild Lead at Myosin.xyz, and an onchain marketing OG, having spent a long career in traditional marketing, and being a critical part of the early days at Dapper Labs, one of the leading onchain companies in the last cycle and beyond. We had a great session yapping with Nicole all around her journey, how she found her way into crypto, lessons learned, and just what has changed in the past four years as the market has continued to evolve. We even had a special guest appearance from a fluffy friend...bark. This ones a great listen for anyone interested in entering crypto! Please enjoy, and tune in live on our Twitter at https://x.com/Myosin_xyz every Wed, at 11am EST.

For EP11 of Chain Reactions, we had a great convo with Will Leatherman (@wleatherman9), Myosin Content Guild Lead, and Founder of Catalyst, a content-led growth platform, chatting all about Founder-Led Marketing. We talked all about the differences between LinkedIn and Twitter content creation, the importance of staying consistent, and some actionable tips and tricks on how to gain traction with founder-led content. If you're interested in growing your audiences and company, this is an excellent listen! Please enjoy, and tune in live on our Twitter at https://x.com/Myosin_xyz every Wed, at 11am EST.

For EP10 of Chain Reactions, we had Crypto Bae (@encryptedbae), a Solana KOl and chain-agnostic marketing extraordinaire, hop on the livestream to jam about onchain marketing. We talked about Solana Villa in Dubai, her fascinating experiment where she offered free chats for her Twitter followers and what she learned, and much more, all while trying not to get distracted by the army of cats running around in the background. What a fun chat! Please enjoy, and tune in live on our Twitter at https://x.com/Myosin_xyz every Wed, at 11am EST.

For EP9 of Chain Reactions, we had Adelia join us again on the livestream to talk about and recap the insanity of Token2049 and Breakpoint in Singapore. Together, we talked about the crazy parties, our key takeaways and favorite events, some major alpha, and also played a fun game of conference bingo, all facetiously sponsored by Bintang Beer. Please enjoy, and tune in live on our Twitter at https://x.com/Myosin_xyz every Wed, at 11am EST!

Drs. Gordon Smith, Shahar Shelly, and Teerin Liewluck discuss the correlation between CMAP duration and myosin loss and their effect on mortality by comparing between patients with CIM with and without myosin loss.  Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000209496 

For EP8 of Chain Reactions, we were joined by 0xSoju, one of the leading cats at Jupiter, the leading DEX aggregator in Solana, to talk all about airdrops and token launches. We also had Xindaquil, a Myosin member and leading marketer in crypto, join us as a co-host. Together, we dove deep into the secret sauce between Jupiter's token launch, their marketing team (or lack thereof), and waxed poetic on what onchain teams should consider when launching a token. Please enjoy, and tune in live on our Twitter at https://x.com/Myosin_xyz every Wed, at 11am EST!

Dr. Gordon Smith talks with Drs. Shahar Shelly and Teerin Liewluck about the correlation between CMAP duration and myosin loss and their effect on mortality by comparing between patients with CIM with and without myosin loss. Read the related article in Neurology.  Disclosures can be found at Neurology.org.

For EP7 of Chain Reactions, we had James Chi, Co-Founder of Camp Network, a fast growing Layer 2 blockchain, tell us all about how Camp is building the future of identity through both offchain and onchain social profiles. We also had a blast diving into Camp's amazing social strategy, and went nuts (in a good way) discussing the power of the Camp community. Please enjoy, and tune in live on our Twitter at https://x.com/Myosin_xyz every Wed, at 11am EST!

Hi, and welcome to Chain Reactions, a weekly livestream from Myosin.xyz, the leading global marketing network, and hosted by yours truly, Blake, and my cohost Polina. Tune in each week as we jam on the latest happenings in the wild and wonderful world of web3. This week we dive into topics such as Berachain, Fuse and is Iggy Azalea actually this involved in memcoins?

This month, how animals hibernate and evidence that muscle myosin makes its own heat in the cold, brain scans to reveal how ketamine relieves resistant depression, the way the brain changes when animals build a bond, the evolution of flu outbreaks, and how aphantasia affects autobiographical memory. Get the references and the transcripts for this programme from the Naked Scientists website

Drop 1: GoDaddy + ENS ⁠https://blog.ens.domains/post/godaddy-partners-with-ens⁠ Drop 2: Cardano migrates to Intersect ⁠https://www.intersectmbo.org/news/open-horizons-cardano-migrates-to-intersect⁠ Drop 3: Farcaster Frames ⁠https://thedefiant.io/socialfi-app-farcaster-s-activity-spikes-after-launching-frames-feature⁠ .. More: FCA review paper on MEV and Oracles ⁠https://www.fca.org.uk/publications/research-notes/research-note-review-maximal-extractable-value-and-blockchain-oracles⁠ Digital Pound Foundation published their response to the BoE Discussion Paper on the Regulatory regime for systemic payment systems using stablecoins and related service providers. ⁠https://www.linkedin.com/posts/jannahpatchay_dpf-response-boe-discussion-paper-on-systemic-ugcPost-7160288781625909248-NRVS⁠ South Korean Regulator to Discuss Spot Bitcoin ETF With U.S. SEC ⁠https://www.coindesk.com/policy/2024/02/05/south-korean-regulator-to-discuss-spot-bitcoin-etf-with-us-sec-report/⁠ Former NBA star Dwight Howard dunks on fans with troublesome NFT launch ⁠https://sportingcrypto.substack.com/p/former-nba-star-dwight-howards-disastrous⁠ Cardano Foundation publishes its 2023 Activity Report ⁠https://cardanofoundation.org/pdf/cardano-foundation-activity-report-2023.pdf⁠ m0 published its whitepaper - Reconstructing the Monetary Stack ⁠https://research.m0.org/research/reconstructing-the-monetary-stack⁠ Softo launches BeyondBold, a new web3 agency ⁠https://sof.to/pt-BR/for-companies/beyondbold-labs⁠ Bitso's new report: Crypto Landscape in Latin America ⁠https://bitso.com/mx/crypto-landscape-2023⁠ Polygon Releases 'Type 1 Prover', promises further ZK interoperability ⁠https://www.coindesk.com/tech/2024/02/08/polygon-releases-type-1-prover-claiming-milestone-set-by-ethereums-vitalik-buterin/⁠ Digitra announces "crypto dividends", a passive income product for assets under custody ⁠https://br.cointelegraph.com/news/crypto-news-digita-announces-new-services-sustainable-bitcoin-on-hathor-and-other-news⁠ Future of Sports Fandom, new report by Sporting Crypto, Myosin and Spartan Labs ⁠https://docsend.com/view/6gy39qmad89qzxb7⁠ Black Mirror and Pixelynx launch smile to earn experience ⁠https://decrypt.co/215410/black-mirror-goes-web3-with-pixelynx-smile-to-earn-experience⁠ Mobiup releases web3 upskill course ⁠https://webitcoin.com.br/mobiup-lanca-curso-capacitar-desenvolvedores-web2/⁠ . Redes sociais / comunicação .. ⁠Instagram.com/blockdropspodcast⁠ .. ⁠Twitter.com/blockdropspod⁠ .. Blockdrops.lens .. ⁠https://warpcast.com/mauriciomagaldi⁠ .. ⁠youtube.com/@BlockDropsPodcast⁠ .. Meu conteúdo em inglês ⁠twitter.com/0xmauricio⁠ .. Newsletter do linkedin ⁠https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7056680685142454272⁠ .. ⁠blockdropspodcast@gmail.com --- Send in a voice message: https://podcasters.spotify.com/pod/show/blockdropspodcast/message

Drop 1: GoDaddy + ENShttps://blog.ens.domains/post/godaddy-partners-with-ensDrop 2: Cardano migrates to Intersecthttps://www.intersectmbo.org/news/open-horizons-cardano-migrates-to-intersectDrop 3: Farcaster Frames https://thedefiant.io/socialfi-app-farcaster-s-activity-spikes-after-launching-frames-feature .. More: FCA review paper on MEV and Oracleshttps://www.fca.org.uk/publications/research-notes/research-note-review-maximal-extractable-value-and-blockchain-oraclesDigital Pound Foundation published their response to the BoE Discussion Paper on the Regulatory regime for systemic payment systems using stablecoins and related service providers.https://www.linkedin.com/posts/jannahpatchay_dpf-response-boe-discussion-paper-on-systemic-ugcPost-7160288781625909248-NRVSSouth Korean Regulator to Discuss Spot Bitcoin ETF With U.S. SEChttps://www.coindesk.com/policy/2024/02/05/south-korean-regulator-to-discuss-spot-bitcoin-etf-with-us-sec-report/Former NBA star Dwight Howard dunks on fans with troublesome NFT launchhttps://sportingcrypto.substack.com/p/former-nba-star-dwight-howards-disastrousCardano Foundation publishes its 2023 Activity Reporthttps://cardanofoundation.org/pdf/cardano-foundation-activity-report-2023.pdfm0 published its whitepaper - Reconstructing the Monetary Stackhttps://research.m0.org/research/reconstructing-the-monetary-stackSofto launches BeyondBold, a new web3 agencyhttps://sof.to/pt-BR/for-companies/beyondbold-labsBitso's new report: Crypto Landscape in Latin Americahttps://bitso.com/mx/crypto-landscape-2023Polygon Releases 'Type 1 Prover', promises further ZK interoperabilityhttps://www.coindesk.com/tech/2024/02/08/polygon-releases-type-1-prover-claiming-milestone-set-by-ethereums-vitalik-buterin/Digitra announces "crypto dividends", a passive income product for assets under custodyhttps://br.cointelegraph.com/news/crypto-news-digita-announces-new-services-sustainable-bitcoin-on-hathor-and-other-newsFuture of Sports Fandom, new report by Sporting Crypto, Myosin and Spartan Labshttps://docsend.com/view/6gy39qmad89qzxb7Black Mirror and Pixelynx launch smile to earn experience https://decrypt.co/215410/black-mirror-goes-web3-with-pixelynx-smile-to-earn-experienceMobiup releases web3 upskill coursehttps://webitcoin.com.br/mobiup-lanca-curso-capacitar-desenvolvedores-web2/ . Redes sociais / comunicação.. Instagram.com/blockdropspodcast.. Twitter.com/blockdropspod.. Blockdrops.lens .. https://warpcast.com/mauriciomagaldi.. youtube.com/@BlockDropsPodcast.. Meu conteúdo em inglês twitter.com/0xmauricio.. Newsletter do linkedin https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7056680685142454272.. blockdropspodcast@gmail.com --- Send in a voice message: https://podcasters.spotify.com/pod/show/blockdropspodcast/message

Genjo Marinello Osho gave this Teisho during the Jan. 14, 2024 Zazenkai at Chobo-Ji. This talk examines how to meet criticisms and mistakes or well or poorly.

Tune in for the first episode of our second season of the official Myosin.xyz podcast, Netcetera, fka W3G! We spoke with Alex Webbs, Innovation Co-Lead at Myosin.xyz, and a member of the Digital Strategy team at PUMA, a leading brand in the world of culture and sports. Alex is a deeply experienced marketer in the world of web3, tech, and culture, having consulted for clients such as Shiseido, Water & Music, NFT.NYC, Ready Player Me, and many more. If you're interested in learning about how brands think about web3 and innovation, this is a great listen. So without further ado, let's get into it. Here is Episode #1 with Alex Webbs!

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/YMA865. CME/MOC/AAPA credit will be available until November 7, 2024.Following the Evolution of Cardiac Myosin Inhibition: Remodeling Clinical Workflows to Realize the Greatest Benefit in oHCM and Beyond In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerMilind Desai, MD, MBA, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Bristol Myers Squibb; Cytokinetics, Incorporated; Medtronic; and Tenaya Therapeutics.Co-Chair/PlannerAnjali Tiku Owens, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for BioMarin Pharmaceutical Inc.; Bristol Myers Squibb; Cytokinetics, Inc.; Edgewise Therapeutics; Lexicon Pharmaceuticals, Inc.; Pfizer; Renovacor, Inc.; Stealth BioTherapeutics; and Tenaya Therapeutics.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/YMA865. CME/MOC/AAPA credit will be available until November 7, 2024.Following the Evolution of Cardiac Myosin Inhibition: Remodeling Clinical Workflows to Realize the Greatest Benefit in oHCM and Beyond In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerMilind Desai, MD, MBA, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Bristol Myers Squibb; Cytokinetics, Incorporated; Medtronic; and Tenaya Therapeutics.Co-Chair/PlannerAnjali Tiku Owens, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for BioMarin Pharmaceutical Inc.; Bristol Myers Squibb; Cytokinetics, Inc.; Edgewise Therapeutics; Lexicon Pharmaceuticals, Inc.; Pfizer; Renovacor, Inc.; Stealth BioTherapeutics; and Tenaya Therapeutics.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/YMA865. CME/MOC/AAPA credit will be available until November 7, 2024.Following the Evolution of Cardiac Myosin Inhibition: Remodeling Clinical Workflows to Realize the Greatest Benefit in oHCM and Beyond In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerMilind Desai, MD, MBA, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Bristol Myers Squibb; Cytokinetics, Incorporated; Medtronic; and Tenaya Therapeutics.Co-Chair/PlannerAnjali Tiku Owens, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for BioMarin Pharmaceutical Inc.; Bristol Myers Squibb; Cytokinetics, Inc.; Edgewise Therapeutics; Lexicon Pharmaceuticals, Inc.; Pfizer; Renovacor, Inc.; Stealth BioTherapeutics; and Tenaya Therapeutics.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/YMA865. CME/MOC/AAPA credit will be available until November 7, 2024.Following the Evolution of Cardiac Myosin Inhibition: Remodeling Clinical Workflows to Realize the Greatest Benefit in oHCM and Beyond In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerMilind Desai, MD, MBA, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Bristol Myers Squibb; Cytokinetics, Incorporated; Medtronic; and Tenaya Therapeutics.Co-Chair/PlannerAnjali Tiku Owens, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for BioMarin Pharmaceutical Inc.; Bristol Myers Squibb; Cytokinetics, Inc.; Edgewise Therapeutics; Lexicon Pharmaceuticals, Inc.; Pfizer; Renovacor, Inc.; Stealth BioTherapeutics; and Tenaya Therapeutics.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/YMA865. CME/MOC/AAPA credit will be available until November 7, 2024.Following the Evolution of Cardiac Myosin Inhibition: Remodeling Clinical Workflows to Realize the Greatest Benefit in oHCM and Beyond In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerMilind Desai, MD, MBA, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Bristol Myers Squibb; Cytokinetics, Incorporated; Medtronic; and Tenaya Therapeutics.Co-Chair/PlannerAnjali Tiku Owens, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for BioMarin Pharmaceutical Inc.; Bristol Myers Squibb; Cytokinetics, Inc.; Edgewise Therapeutics; Lexicon Pharmaceuticals, Inc.; Pfizer; Renovacor, Inc.; Stealth BioTherapeutics; and Tenaya Therapeutics.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/YMA865. CME/MOC/AAPA credit will be available until November 7, 2024.Following the Evolution of Cardiac Myosin Inhibition: Remodeling Clinical Workflows to Realize the Greatest Benefit in oHCM and Beyond In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerMilind Desai, MD, MBA, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Bristol Myers Squibb; Cytokinetics, Incorporated; Medtronic; and Tenaya Therapeutics.Co-Chair/PlannerAnjali Tiku Owens, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for BioMarin Pharmaceutical Inc.; Bristol Myers Squibb; Cytokinetics, Inc.; Edgewise Therapeutics; Lexicon Pharmaceuticals, Inc.; Pfizer; Renovacor, Inc.; Stealth BioTherapeutics; and Tenaya Therapeutics.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

Please visit answersincme.com/PBR860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in managing hypertrophic cardiomyopathy (HCM) discuss best practices for diagnosis and evidence-based strategies using cardiac myosin inhibitors. Upon completion of this activity, participants should be better able to: Identify best practices to optimally diagnose patients with HCM in order to improve patient outcomes; Describe the clinical impact of cardiac myosin inhibitors in managing patients with obstructive HCM; and Outline practical strategies to incorporate cardiac myosin inhibitors into treatment plans for patients with obstructive HCM.

For Ep. 20 of W3G, our final episode of this season, we're joined by Sean Clayton, one of our Co-Founders at Myosin. We had a great time talking about Sean & Myosin's origin story, why human beings are blockchains & the world is AI, the implications of emerging tech for brands, and how Myosin is evolving as we progress into the next generation of the internet. This is a great episode to expand your thinking and to really understand where the future of brand building is headed, as technology continues to take on a growing importance in our everyday lives.

With all the buzz about Web3 and technological advancements, marketing and agency life is poised to change rapidly. One agency model that works well in the Web3 world is a DAO, or Decentralized Autonomous Organization. Today, Matthew Mozzocchi is here to talk about Myosin, a DAO agency, and how this model allows them to have a leg up the Web3 world. This week, episode 190 of The Digital Agency Growth Podcast is about Web 3, the DAO team model, and profitable agency partnerships!Are you leaving money on the table with your proposals? Introducing Smart Pricing Table, the ultimate agency proposal software with built-in upsell features. Maximize your revenue potential today. Download our Sponsor's free guide, the Profitable Proposal Blueprint, today. In this episode of The Digital Agency Growth Podcast, Matthew Mozzocchi shares the importance of partnering with agencies in a mutually beneficial way and actionable steps you can take right now to understand the underlying tech of Web3.Matthew Mozzocchi is the Head of Revenue Operations at Myosin, a product studio and agency leveraging the collective wisdom of our member base to inform the tools, processes and playbooks that drive user acquisition into web3. Matthew also helps agencies and Fortune 100 businesses solve their complex staffing needs with flexible talent solutions. In this episode, Dan and Matthew discuss the following:What a DAO (Decentralized Autonomous Organization) is and how it works.The value of partnership models that actually benefit both parties.How Web3 and Web2 differ and how we can expect to see Web3 grow in the next few years.The importance of getting in front of different audiences when partnering.Thank you for listening! If you enjoyed this episode, please take a moment to follow, rate and review the podcast and tell me your key takeaways!Learn more about The Digitial Agency Growth Podcast at https://www.salesschema.com/podcast/ and Smart Pricing Table at https://www.smartpricingtable.com/dagCONNECT WITH MATTHEW MOZZOCCHI:LinkedInMozz.coMyosin.xyzCONNECT WITH DAN ENGLANDER:LinkedInSales Schema

This podcast episode explores new advances in treating obstructive hypertrophic cardiomyopathy (HCM) and the role of myosin inhibitors, and provides an overview of the EXPLORER-HCM and VALOR-HCM clinical trials. Iacopo Olivotto, University of Florence, Italy, first discusses unmet medical needs, specifically regarding the unmet needs of patients and gaps in current treatment methods. The discussion then centres around the mechanism of action of myosin inhibitors, a first-in-class drug for HCM, recently approved by the European Medicines Agency (EMA). The findings of current clinical trials are outlined, with results being linked to a reduced need for septal reduction therapy, in addition to improved quality of life for patients. Finally, case studies are presented, discussing the impact of treatments on the lives of patients with HCM, and how to best integrate new treatments into current practice.

Welcome to the official recap of “Myosin Gathers #1: The State of Metaverse & Immersive Media." If you missed out on this groundbreaking webinar, don't worry. We've got you covered with all the highlights and key takeaways. In 2023, the metaverse has become more than just a buzzword – it's a rapidly evolving reality. This webinar delved into the current state of the metaverse and explored how brands should approach it as a vital component of their digital and marketing strategies. But what exactly is the metaverse and how does immersive media fit into the picture? Our esteemed panel of experts from Mona, EveryRealm, and Decentraland gathered in the Mona Space, a metaverse of its own, to provide deep insights and thought-provoking discussions. Together, they explored the potential of the metaverse, its impact on mainstream users, and its significance in the realm of web3. This webinar was a valuable opportunity for brands, mainstream users, and web3 enthusiasts to gain valuable insights from industry leaders and shape their understanding of the metaverse. The discussions were both thought-provoking and inspiring, opening up new possibilities for future collaborations and ventures. Time stamps: 00:02:27 The metaverse is immersive media. 00:06:40 Metaverse adoption faces behavior hurdles. 00:10:44 The future of brands in metaverse. 00:16:18 Brands should enhance mixed-reality experiences. 00:21:45 Web3 and decentralization are future. 00:27:12 Community building is essential. 00:31:21 Metaverse community and hardware evolution. 00:36:21 Using computer's GPU for WebGL experiences. 00:41:28 Interoperability key to metaverse. 00:46:30 Metaverse is better with friends.

My guest today is Simon Yi (https://twitter.com/da0uch ), founder of Myosin.xyz (https://twitter.com/Myosin_xyz ), a global network of marketers building marketing tools that accelerate the direct to community movement. Simon is what we would call an OG. He started as Head of Growth at Consensys Mesh in 2020 where helped grow staple brands like Chainlink and Filecoin. He is the most experienced growth marketer we've had on the show. While numbers are a massive part of Simon's expertise, he doesn't hesitate to do some deeper philosophical thinking about the unique value offered by blockchain. We Discuss...From the very start of the episode, we are talking numbers. Dunbar's number. What is a healthy percentage of retention and activity in Discord. Myosin aims to create a reputation system for Web3, offering a new model for creators, brands, and communities to engage with their audiences and stakeholders.Reputation scores in Myosin are designed to be a combination of on-chain and off-chain factors, rewarding positive behavior and encouraging collaboration within communities.Tokenized online communities, such as Friend with Benefits (“FWB”) and DAOs, demonstrate the potential of Web3 to change the way people interact, collaborate, and generate value together.The adoption and growth of Web3 technology will depend on its ability to address real-world problems, such as copyright and attribution for artists and creators.FWB's partnership with a liquor brand showcases how blockchain and smart contracts can automate revenue sharing, providing a new way for brands to partner to provide unique experiences for communities and automate the terms.Localized Web3 communities, similar to Facebook groups or neighborhood-based groups, present a significant opportunity for innovation and growth in the space.Simon, the founder of Myosin, envisions Web3 succeeding through the formation of "network states," which are interest-based communities that transcend geographic borders.In the next six to twelve months, Myosin aims to mint its first on-chain reputation score, potentially unlocking a new phase of growth for the platform.Chapters:00:00 Introduction and Background03:24 The Idea Behind Myosin08:42 Web3's Impact on Creators13:51 Relevance of Reputation Scores19:03 Onboarding Artists and Creators25:26 Tokenizing Online Communities31:07 Web3's Adoption and Growth 37:03 Social Tokens and the Future of Communities 49:51 Brands Leveraging Blockchain Technologies 53:20 Opportunities in Localized Web3 Communities Thanks for listening! Did you know you can also watch the show on YouTube? Just hit the link below and don't forget to subscribe!Web3 w/ Me - YouTube

Here's a special bonus episode from our first public Gather.Town, Women Leading the Web3 Revolution, w/ Evin from Disco.xyz, Nicole from Seed Club, and Rachel from Opolis. Hear from the women that are changing the game in web3! Listen in on this panel discussion dissecting and highlighting how women are genuinely impacting, shaping, and improving the space by bringing their own unique perspectives and strengths. . SHOW NOTES: See below for where you can find our panelists and what they're working on! Evin McMullen: https://twitter.com/provenauthority and https://twitter.com/discoxyz / https://www.disco.xyz/ Nicole D'avis: https://twitter.com/mybellalogica and https://twitter.com/seedclubhq / https://www.seedclub.xyz/ Rachel Brissenden: https://twitter.com/RachelRoseB and https://twitter.com/opolis / https://opolis.co/

Host Kevin Patton revisits some classic segments from past episodes. In the first segment, he explains why he thinks storytelling is the heart of effective teaching. Then. he tells a brief version of his actin-myosin love story—a playful analogy to help students learn about muscle contraction. 00:00 | Introduction 01:07 | Storytelling: The Heart of Teaching 15:36| Sponsored by AAA, HAPI, and HAPS 17:10 | Actin-Myosin Love Story 27:58 | Staying Connected ★ If you cannot see or activate the audio player, go to: theAPprofessor.org/podcast-episode-130.html

Here are some guided questions to ask yourself as we move through this lesson! It's good stuff I promise... Within the word Sarcopenia, the root word “SARCO-” refers to _______________. When etymologizing the word “Sarcoma”, “sarc-“ + “-oma” literally means what?____________________________ Hippocrates named masses of cancerous cells as “Karkinos.” What does Karkinos mean is English? ___________________ Sarcophagus' literal meaning is: “________________” + “________________” In Sarcomere, “-mere” means ______________ in English. A Sarcomere is made up of __________ and Myosin. In the word Autophagy, “Auto-” refers to _____________. If “BIOGRAPHY” means “A study of life,” then what do you think AUTObiography? _______________________________________________ “phago-” + “cyte” = “_____________________” In the term “CYTOPENIA”, the suffix “-penia” means: __________________ “Thrombo-” + “cytes” = ____________________________ Thrombocytes help to form ________________ to slow or stop bleeding and to help wounds heal. What do you think it means when you have a “-penia” of thrombocytes? AKA… Thrombocytopenia? Circle the correct answer: Do hemophilia and thrombocytopenia go hand in hand? True or False What does the prefix “hemo-” mean? “_______________” The root word “OSTEO” means _________________ Circle the correct answer: Is bone porous in nature? True or False Osteoporosis = “a” + “b” + “c” = _____________________________________ --- Support this podcast: https://anchor.fm/liam-connerly/support